Mckenzie Melanie, Johnson Jacinta L, Anderson Karen, Summers Richard, Wood Pene
Department of Pharmacy and Biomedical Science, College of Science, Health & Engineering, La Trobe University. Bendigo, VIC (Australia).
School of Pharmacy and Medical Sciences, University of South Australia. Adelaide, SA (Australia).
Pharm Pract (Granada). 2020 Apr-Jun;18(2):1904. doi: 10.18549/PharmPract.2020.2.1904. Epub 2020 Jun 1.
Explore the perceptions, attitudes and experiences of pharmacists relating to the up-scheduling of low dose codeine containing analgesics and the impact on pharmacy practice.
A mixed design method was used consisting of an anonymous online questionnaire survey to quantitatively capture broad pre-scheduling change perceptions paired with a series of in-depth post-scheduling semi-structured interviews to provide a qualitative picture of the impact of codeine up-scheduling on pharmacy practice in Australia.
A total of 191 pharmacists completed the quantitative survey and 10 participated in the in-depth interview. The majority of respondents supported the decision to up-schedule over-the-counter combination products containing codeine to some degree. Three main themes emerged from the data: pharmacists' perceptions of the codeine up-scheduling decision, preparing for the up-schedule and impact of the up-schedule on pharmacy practice. Pharmacists were concerned about the impact of up-scheduling on the pharmacy business, patient access to pain relief and the diminishment of their professional role.
There were diverse perceptions, preparedness and impact on practice regarding the up-scheduling of low dose codeine products. Further research should be conducted to gauge if and how these perceptions have changed over time and to identify whether pain is being managed more effectively post codeine up-scheduling.
探讨药剂师对含低剂量可待因镇痛药上调处方级别的看法、态度和经历,以及对药房业务的影响。
采用混合设计方法,包括一项匿名在线问卷调查,以定量获取处方级别调整前的广泛看法,同时进行一系列处方级别调整后的深度半结构化访谈,以定性描述可待因上调处方级别对澳大利亚药房业务的影响。
共有191名药剂师完成了定量调查,10人参与了深度访谈。大多数受访者在一定程度上支持将含可待因的非处方复方产品上调处方级别的决定。数据中出现了三个主要主题:药剂师对可待因上调处方级别决定的看法、为上调做准备以及上调对药房业务的影响。药剂师担心上调对药房业务、患者获得止痛药物的机会以及他们专业角色的削弱所产生的影响。
对于低剂量可待因产品上调处方级别,存在不同的看法、准备情况和对业务的影响。应进一步开展研究,以评估这些看法是否以及如何随时间变化,并确定可待因上调处方级别后疼痛管理是否更有效。